The ameloblastoma mainly occurs in the mandible, rarely seen in the soft tissues. This paper reported 1 case of mandibular gingival peripheral ameloblastoma, and discussed its treatment based on literature review.
Download full-text PDF |
Source |
---|
Cureus
November 2024
Oral and Maxillofacial Surgery, Burdwan Dental College and Hospital, Burdwan, IND.
Peripheral ameloblastoma is a rare, benign, slow-growing odontogenic neoplasm prevalent in the mandible. It originates from the odontogenic epithelium and its remnants, and its histological characteristics are identical to those of intraosseous ameloblastoma. It is less aggressive and invasive than its intraosseous variety, with a low recurrence rate.
View Article and Find Full Text PDFJ Clin Med
November 2024
Department of Biomedical, Surgical and Dental Sciences, University of Milan, 20142 Milan, Italy.
Peripheral ameloblastoma (PA) is a rare benign tumor that can occur mostly in the mandibular gingiva of the premolar area, originating from the residual odontogenic epithelium. The patient is usually asymptomatic and the lesion can be an occasional finding during routine intraoral examination. Due to the lack of clinical and radiographic pathognomonic features, the diagnosis is based on histopathological analysis, associated with 3D computed tomography (CT) imaging.
View Article and Find Full Text PDFJ Korean Assoc Oral Maxillofac Surg
October 2024
Department of Oral and Maxillofacial Surgery and Periodontology, Ribeirão Preto Dental School, University of São Paulo, Ribeirão Preto, Brazil.
Semin Diagn Pathol
October 2024
Department of Oral Pathology & Microbiology, King George's Medical University, Lucknow 226003, UP, India. Electronic address:
J Craniofac Surg
January 2025
Hospital Sultan Abdul Halim, Ministry of Health Malaysia, Kedah.
Introduction: Ameloblastoma is a slow-growing benign odontogenic tumor of the jaws. The objectives of this study were to evaluate the epidemiological data of ameloblastoma in Kedah, to identify the clinicopathological characteristics that predict the outcome of the treatment and recurrence rate.
Methodology: A retrospective cohort study was conducted for patients who underwent treatment for ameloblastoma from 2007 to 2021.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!